Beschreibung
Gabapentin and valproic acid have a minor pharmacokinetic interaction; valproate may slightly increase gabapentin renal clearance.
Mechanismus
Gabapentin is renally excreted unchanged; valproate may slightly alter renal tubular handling of gabapentin but the clinical effect is minor.
Klinische Bedeutung
The interaction is generally not clinically significant; however, combined CNS depressant effects can cause additive sedation.
Maßnahmen
Monitor for excessive sedation; dose adjustments are rarely required for the pharmacokinetic component of this interaction.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.